WE AIM TO CONDUCT A RANDOMIZED, CONTROLLED CLINICAL TRIAL IN CRITICALLY ILL PATIENTS WITH SEVERE PNEUMONIA RECEIVING BETA-LACTAM THERAPY AS CONTINUOUS VS. INTERMITTENT INFUSION FOR GRAM-NEGATIVE INFECTIONS AND ASSESS THE DEVELOPMENT OF NEW BACTERIA

DEFINITIVE CONTRACT won by UNIVERSITY OF FLORIDA · work in SILVER SPRING, MD
$499,445
RecipientUNIVERSITY OF FLORIDA UEI NNFQH1JAPEP3
Award ID75F40121C00157
Award amount$499,445
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Food and Drug Administration
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN11
Start dateSep 28, 2021
End dateSep 29, 2023
Place of performanceSILVER SPRING, MD
Record updatedApr 2, 2022

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids